课题基金 / 基金详情

Bioreactor-based large scale production of a Tim-3 pathway inhibitor as a novel immunotherapy against HIV-1 and other chronic viral infections

Bioreactor-based large scale production of a Tim-3 pathway inhibitor as a novel immunotherapy against HIV-1 and other chronic viral infections
基于生物反应器大规模生产 Tim-3 通路抑制剂作为针对 HIV-1 和其他慢性病毒感染的新型免疫疗法
批准号:
174453
负责人:
Ostrowski Mario A
金额:
$10.93万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2008
资助国家:
加拿大
项目状态:
已结题
起止时间:
2008-10-01 至 2009-10-01

项目摘要

项目成果

Ostrowski Mario A的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
One of the greatest mysteries of Human Immunodeficiency Virus Type 1 (HIV-1) infection has been to understand why the normal immune system is unable to eradicate or control this virus infection as opposed to other virus infections. Our laboratory speciali
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CD8 T cell based eradication of HIV reservoirs: toward a personalized approach to HIV cure therapy
  • 批准号:
    404215
  • 项目类别:
    Operating Grants
  • 资助金额:
    $145.7万
  • 财政年份:
    2018
  • 负责人:
    Ostrowski Mario A
  • 依托单位:
CEACAM-1 and TIM-3 interactions in HIV reservoir establishment, persistence and evasion from HIV specific immunity.
  • 批准号:
    371636
  • 项目类别:
    Operating Grants
  • 资助金额:
    $50.16万
  • 财政年份:
    2017
  • 负责人:
    Ostrowski Mario A
  • 依托单位:
Developing a Novel Modular Nanoparticle Vaccine Strategy to Induce Durable Systemic and Mucosal HIV Envelope Specific Antibodies
  • 批准号:
    365746
  • 项目类别:
    Operating Grants
  • 资助金额:
    $18.21万
  • 财政年份:
    2017
  • 负责人:
    Ostrowski Mario A
  • 依托单位:
The metabolic basis of T cell exhaustion in HIV infection: discovery of novel treatment targets
  • 批准号:
    354423
  • 项目类别:
    Operating Grants
  • 资助金额:
    $49.04万
  • 财政年份:
    2016
  • 负责人:
    Ostrowski Mario A
  • 依托单位:
海外基金